Comparison of Treatment of Severe High-Density Lipoprotein Cholesterol Deficiency in Men With Daily Atorvastatin (20 mg) Versus Fenofibrate (200 mg) Versus Extended-Release Niacin (2 g)

Khalid Alrasadi, Zuhier Awan, Khalid Alwaili, Isabelle Ruel, Anouar Hafiane, Larbi Krimbou, Jacques Genest

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

To determine whether available lipid-modifying medication can increase high-density lipoprotein (HDL) cholesterol in well-defined genetic or familial HDL-deficiency states, we studied 19 men with HDL deficiency (HDL cholesterol

Original languageEnglish
Pages (from-to)1341-1347
Number of pages7
JournalAmerican Journal of Cardiology
Volume102
Issue number10
DOIs
Publication statusPublished - Nov 15 2008

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Comparison of Treatment of Severe High-Density Lipoprotein Cholesterol Deficiency in Men With Daily Atorvastatin (20 mg) Versus Fenofibrate (200 mg) Versus Extended-Release Niacin (2 g)'. Together they form a unique fingerprint.

  • Cite this